Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boogaerts

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
British Journal of Clinical Practice. Supplement|February 1, 1988
Empiric antibiotic therapy in the neutropenic patientM Boogaerts
Drugs|February 24, 2001
Clinical experience with itraconazole in systemic fungal infectionsM Boogaerts, J Maertens
American Journal of Hematology|April 1, 1991
Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndromeG Verhoef, M Boogaerts
The Journal of the Royal College of Physicians of Edinburgh|January 24, 2004
Clinical features suggestive of lymphadenopathy in a painting by Marinus Van ReymerswaeleJ Dequeker, M Boogaerts
British Journal of Haematology|October 1, 1991
In vivo administration of granulocyte-macrophage colony stimulating factor enhances neutrophil function in patients with myelodysplastic syndromesG Verhoef, M Boogaerts
British Journal of Haematology|June 1, 1988
Do members of Li-Fraumeni families always carry an HLA antigen Cw3 together with unexplained high transcortin levelsP De Moor, M Boogaerts
Leukemia|July 1, 1987
A subgroup of all patients delimitated by two inherited factorsP De Moor, M Boogaerts
European Journal of Cancer Care|February 6, 2002
Assessing risk factors for systemic fungal infectionsJ Maertens, M Vrebos, M Boogaerts
British Journal of Cancer|April 3, 2003
Impact of epoetin beta on quality of life in patients with malignant diseaseM Boogaerts, B Coiffier, C Kainz, et al.
British Journal of Haematology|June 1, 1988
More familial leukaemia in ALL patients with both unexplained high transcortin levels and an HLA antigen Cw3P De Moor, M Boogaerts, A Louwagie
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
British Journal of Clinical Practice. Supplement|February 1, 1988
Empiric antibiotic therapy in the neutropenic patientM Boogaerts
Drugs|February 24, 2001
Clinical experience with itraconazole in systemic fungal infectionsM Boogaerts, J Maertens
American Journal of Hematology|April 1, 1991
Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndromeG Verhoef, M Boogaerts
The Journal of the Royal College of Physicians of Edinburgh|January 24, 2004
Clinical features suggestive of lymphadenopathy in a painting by Marinus Van ReymerswaeleJ Dequeker, M Boogaerts
British Journal of Haematology|October 1, 1991
In vivo administration of granulocyte-macrophage colony stimulating factor enhances neutrophil function in patients with myelodysplastic syndromesG Verhoef, M Boogaerts
British Journal of Haematology|June 1, 1988
Do members of Li-Fraumeni families always carry an HLA antigen Cw3 together with unexplained high transcortin levelsP De Moor, M Boogaerts
Leukemia|July 1, 1987
A subgroup of all patients delimitated by two inherited factorsP De Moor, M Boogaerts
European Journal of Cancer Care|February 6, 2002
Assessing risk factors for systemic fungal infectionsJ Maertens, M Vrebos, M Boogaerts
British Journal of Cancer|April 3, 2003
Impact of epoetin beta on quality of life in patients with malignant diseaseM Boogaerts, B Coiffier, C Kainz, et al.
British Journal of Haematology|June 1, 1988
More familial leukaemia in ALL patients with both unexplained high transcortin levels and an HLA antigen Cw3P De Moor, M Boogaerts, A Louwagie
Pageof 11